COLL News

14 companies were scheduled to go public this week, including 10 health care deals. Only 8 IPOs got through, as 3 biotechs have been pushed back to next week, two companies postponed and one withdrew. however; IPO investors had plenty of options while the NASDAQ composite hit a 1-month low. This week's deals did include the year's largest IPO so far and the first restaurant chain...read more

Collegium Pharmaceutical, which is developing an abuse-deterrent oral formulation of oxycodone for pain, raised $70 million by offering 5.8 million shares at $12, the low end of the range of $12 to $14. Collegium Pharmaceutical plans to list on the NASDAQ under the symbol COLL. Collegium Pharmaceutical initially filed confidentially on 3/3/2015. Jefferies & Co. and Piper...read more

This could be the busiest 5-day stretch in the IPO market since the week of July 28, 2014, as 14 companies look to raise nearly $2 billion. However, last week's mediocre returns suggest that ...read more

Collegium Pharmaceutical, which is developing an abuse-deterrent oral formulation of oxycodone for pain, announced terms for its IPO on Monday. The Canton, MA-based company plans to raise $75 million by offering 5.8 million shares at a price range of $12 to $14. At the midpoint of the proposed range, Collegium Pharmaceutical would command a market value of $256 million. ...read more